Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian [Phase 1]
Phase 1 trial update of neoadjuvant chemotherapy with weekly paclitaxel, carboplatin, and bevacizumab for ovarian and related cancers; study…
-
CLINICAL_TRIALS research · 2015-06-23Clinical Trial Update: DNA Single Nucleotide Polymorphisms as Predictors of Toxicity
The document describes an ongoing clinical trial investigating whether DNA single nucleotide polymorphisms can predict treatment toxicity in…
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer [Phase 2]
Phase 2 trial update of carboplatin and paclitaxel in elderly women with newly diagnosed ovarian, primary peritoneal, or related cancers; st…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating rhuMab 2C4 with gemcitabine in ovarian, primary peritoneal, and fallopian tube cancers has completed enr…
-
CLINICAL_TRIALS trial_result · 2015-05-25Clinical Trial Update: SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin [Phase 2]
Phase 2 trial of SJG-136 in recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer that failed cisplatin/carboplatin was…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for pazopanib/doxorubicin in relapsed platinum-sensitive or resistant ovarian, fallopian tube, or primary peritoneal a…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers [Phase 2]
Phase 2 trial evaluating weekly topotecan with bevacizumab in platinum-resistant/recurrent gynecologic cancers; the study (including ovarian…
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 study of polyglutamate paclitaxel in combination with carboplatin for ovarian epithelial, fallopian tube, and primary peritoneal can…
-
CLINICAL_TRIALS research · 2015-05-06Clinical Trial Update: p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer [Phase 2]
This is an update on a Phase 2 clinical trial evaluating a p53 gene therapy for recurrent ovarian epithelial cancer, fallopian tube cancer, …
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer [Phase 2, Phase 3]
A phase 2/3 trial evaluated the combination of saracatinib with paclitaxel in platinum-resistant ovarian cancer, including fallopian tube an…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of gemcitabine, carboplatin, and bevacizumab for ovarian cancer, fallopian tube cancer, or…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor [Phase 2]
Phase 2 clinical trial update evaluating imatinib mesylate in patients with refractory or relapsed ovarian epithelial cancer, fallopian tube…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Advanced Cancer [Phase 1]
A Phase 1 trial of immunotoxin therapy in patients with advanced cancers has completed, with results spanning several gynecologic and non-gy…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial of an immunotoxin therapy in patients with advanced solid tumors has completed, spanning eight cancer types including cervical…
-
CLINICAL_TRIALS trial_result · 2015-03-26Clinical Trial Update: Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating sorafenib in combination with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers; study comple…
-
CLINICAL_TRIALS trial_result · 2015-03-23Clinical Trial Update: Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer [NA]
This Northwestern University-sponsored trial evaluated Vitamin D supplementation for women at increased risk of ovarian, fallopian tube, or …
-
CLINICAL_TRIALS trial_result · 2015-03-11Clinical Trial Update: VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating VEGF Trap with docetaxel in persistent or recurrent ovarian epithelial cancer, primary peritoneal cancer, or fall…
-
CLINICAL_TRIALS trial_result · 2015-03-03Clinical Trial Update: A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers [Phase 2]
Phase II trial evaluating debulking surgery with HIPEC followed by intraperitoneal chemotherapy for recurrent ovarian, primary peritoneal, a…
-
CLINICAL_TRIALS trial_result · 2015-02-18Clinical Trial Update: Vinorelbine and Gemcitabine Combination In Platinum Resistant Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial of vinorelbine plus gemcitabine for platinum-resistant recurrent ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-02-03Clinical Trial Update: Birinapant for Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer [Phase 2]
Phase 2 trial of birinapant in advanced epithelial ovarian, fallopian tube, and peritoneal cancers was terminated; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Positron Emission Tomography/Computed Tomography (PET/CT) in Relapsed Ovarian Cancer (MK-0000-143) [Phase 1]
Phase 1 trial update evaluating PET/CT imaging with MK-0000-143 in relapsed ovarian cancer, primary peritoneal cancer, and fallopian tube ca…
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
A Phase 2 clinical trial evaluating sunitinib malate in patients with recurrent ovarian epithelial cancer, fallopian tube cancer, or primary…
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Pharmacogenomics of Paclitaxel in Ovarian Cancer
This Clinical Trial Update documents the completion of a pharmacogenomics study evaluating how genetic variation influences paclitaxel treat…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 evaluation of cisplatin plus paclitaxel in patients with advanced ovarian epithelial cancer, fallopian tube cancer, or primary perit…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer [Phase 1]
Phase 1 trial investigating carboplatin, paclitaxel, and pegfilgrastim in patients with Stage III/IV ovarian epithelial, fallopian tube, pri…